These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21266513)

  • 1. A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients.
    de Vries-Sluijs TE; Hansen BE; van Doornum GJ; Kauffmann RH; Leyten EM; Mudrikova T; Brinkman K; den Hollander JG; Kroon FP; Janssen HL; van der Ende ME; de Man RA
    J Infect Dis; 2011 Apr; 203(7):984-91. PubMed ID: 21266513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
    Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
    Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
    Mena G; Llupià A; García-Basteiro AL; Díez C; León A; García F; Bayas JM
    Vaccine; 2012 May; 30(24):3703-9. PubMed ID: 22446635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.
    Tedaldi EM; Baker RK; Moorman AC; Wood KC; Fuhrer J; McCabe RE; Holmberg SD;
    Clin Infect Dis; 2004 May; 38(10):1478-84. PubMed ID: 15156488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P; Jongjirawisan Y; Atamasirikul K; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):680-5. PubMed ID: 17883006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.
    van den Berg R; van Hoogstraten I; van Agtmael M
    AIDS Rev; 2009; 11(3):157-64. PubMed ID: 19654857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
    Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
    HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
    Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
    JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis B vaccination effectiveness based on anti-HBs antibodies presence in children vertically infected with HIV].
    Ołdakowska A; Marczyńska M
    Przegl Epidemiol; 2010; 64(2):323-8. PubMed ID: 20731246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
    Cruciani M; Mengoli C; Serpelloni G; Lanza A; Gomma M; Nardi S; Rimondo C; Bricolo F; Consolaro S; Trevisan M; Bosco O
    Vaccine; 2009 Jan; 27(1):17-22. PubMed ID: 18984022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.
    de Vries-Sluijs TE; Hansen BE; van Doornum GJ; Springeling T; Evertsz NM; de Man RA; van der Ende ME
    J Infect Dis; 2008 Jan; 197(2):292-4. PubMed ID: 18177248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
    Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose.
    Fonseca MO; Pang LW; de Paula Cavalheiro N; Barone AA; Heloisa Lopes M
    Vaccine; 2005 Apr; 23(22):2902-8. PubMed ID: 15780739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.
    Veiga AP; Casseb J; Duarte AJ
    Vaccine; 2006 Nov; 24(49-50):7124-8. PubMed ID: 16884833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals.
    Horster S; Laubender RP; Lehmeyer L; Ankerst DP; Eberle J; Reinert R; Imöhl M; van der Linden M; Schweiger B; Bogner JR
    J Infect; 2010 Dec; 61(6):484-91. PubMed ID: 20875454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.
    Cooper CL; Angel JB; Seguin I; Davis HL; Cameron DW
    Clin Infect Dis; 2008 Apr; 46(8):1310-4. PubMed ID: 18444872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.